Multivessel percutaneous coronary intervention in patients with stable angina

• Verfasst von: Bauer, Timm [VerfasserIn]
• Verfasst von: Zeymer, Uwe [VerfasserIn]
• Verfasst von: Hochadel, Matthias [VerfasserIn]
• Verfasst von: Zahn, Ralf [VerfasserIn]
• Verfasst von: Gitt, Anselm Kai [VerfasserIn]
• Titel: Multivessel percutaneous coronary intervention in patients with stable angina
• Titelzusatz: a common approach? Lessons learned from the EHS PCI registry
• Verf.angabe: Timm Bauer, Helge Möllmann, Uwe Zeymer, Matthias Hochadel, Holger Nef, Franz Weidinger, Ralf Zahn, Christian W. Hamm, Jean Marco, Anselm K. Gitt
• Jahr: 2012
• Jahr des Originals: 2011
• Umfang: 7 S.
• Fussnoten: First online: 09 November 2011 ; Gesehen am 09.11.2018
• Titel Quelle: Enthalten in: Heart and vessels
• Ort Quelle: Tokyo : Springer, 1985
• Jahr Quelle: 2012
• Band/Heft Quelle: 27(2012), 5, Seite 453-459
• ISSN Quelle: 1615-2573
• DOI: doi:10.1007/s00380-011-0207-4
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: Clinical practice
• Sach-SW: Multivessel disease
• Sach-SW: Percutaneous coronary intervention
• K10plus-PPN: 1583056971

Abstract

The aim of this study was to evaluate clinical characteristics, procedural details, and outcomes of patients undergoing elective multivessel percutaneous coronary intervention (MV-PCI) in Europe. A total of 7113 patients with stable coronary artery disease and at least two major epicardial vessels with ≥70% stenosis were included in this analysis of the contemporary Euro Heart Survey PCI registry. Patients undergoing MV-PCI (n = 3376, 47.5%) were compared with those with single-vessel PCI (SV-PCI) (n = 3737, 52.5%). Patients with MV-PCI were more likely to have congestive heart failure, whereas those with SV-PCI more often suffered from noncardiac comorbidities. Hospital mortality (0.1% vs 0.3%) and the incidence of nonfatal postprocedural myocardial infarction (1.0% vs 0.7%) were low in patients with MV-PCI and SV-PCI. In the multivariate analysis, no significant difference in the incidence of hospital death (odds ratio (OR) 0.44, 95% confidence interval (CI) 0.15-1.27) could be observed between the two groups. However, the risk for postprocedural myocardial infarction (OR 1.57, 95% CI 0.93-2.67) tended to be higher among patients undergoing MV-PCI. Independent determinants for performing MV-PCI were age, comorbidities, and coronary anatomy. In Europe almost half of all patients with multivessel disease were treated with MV-PCI. Hospital complications were low, but a trend toward a higher rate of postprocedural myocardial infarctions was seen in patients with MV-PCI.